APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Remedies

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dermatological Remedies Market Analysis and Forecast 2026-2032

Report ID 173983530219 December 2025207 pages

Choose your research edition.

Industry ResearchDermatological Remedies Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Remedies Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Dermatological Remedies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Remedies Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Remedies Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Dermatological Remedies market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Dermatological Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dermatological Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dermatological Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dermatological Remedies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Dermatological Remedies include Teva, Sun Pharmaceutical, Johnson & Johnson, Qilu Pharmaceutical, Novartis, Mylan, GSK, Bayer and Lupin, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Dermatological Remedies, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dermatological Remedies, also provides the revenue of main regions and countries. Of the upcoming market potential for Dermatological Remedies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dermatological Remedies revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dermatological Remedies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Dermatological Remedies revenue, projected growth trends, production technology, application and end-user industry.

Dermatological Remedies Segment by Company

Teva

Sun Pharmaceutical

Johnson & Johnson

Qilu Pharmaceutical

Novartis

Mylan

GSK

Bayer

Lupin

Lingrui

Galderma

Dr. Reddy's

CR SANJIU

Cipla

Bausch Health

Aurobindo

Almirall

Dermatological Remedies Segment by Type

Anti-acne

Anti-infectives

Anti Psoriasis

Corticosteroids

Others

Dermatological Remedies Segment by Application

Hospital

Clinic

Dermatological Remedies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Remedies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Remedies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Remedies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Dermatological Remedies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Dermatological Remedies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dermatological Remedies revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dermatological Remedies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anti-acne Major Player Table 3. Anti-infectives Major Player Table 4. Anti Psoriasis Major Player Table 5. Corticosteroids Major Player Table 6. Others Major Player Table 7. Global Dermatological Remedies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Player Table 9. Clinic Major Player Table 10. Dermatological Remedies Industry Trends Table 11. Dermatological Remedies Industry Drivers Table 12. Dermatological Remedies Industry Opportunities and Challenges Table 13. Dermatological Remedies Industry Restraints Table 14. Global Dermatological Remedies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Dermatological Remedies Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Dermatological Remedies Market Share by Region (2021-2026) Table 17. Global Dermatological Remedies Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Dermatological Remedies Market Share by Region (2027-2032) Table 19. Global Dermatological Remedies Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Dermatological Remedies Revenue Market Share by Players (2021-2026) Table 21. Global Dermatological Remedies Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Dermatological Remedies Key Players Headquarters & Area Served Table 23. Global Dermatological Remedies Players, Product Type & Application Table 24. Global Dermatological Remedies Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Dermatological Remedies by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Dermatological Remedies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Dermatological Remedies Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Dermatological Remedies Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Dermatological Remedies Revenue Market Share by Type (2021-2026) Table 31. Global Dermatological Remedies Revenue Market Share by Type (2027-2032) Table 32. Global Dermatological Remedies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Dermatological Remedies Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Dermatological Remedies Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Dermatological Remedies Revenue Market Share by Application (2021-2026) Table 36. Global Dermatological Remedies Revenue Market Share by Application (2027-2032) Table 37. Teva Company Information Table 38. Teva Business Overview Table 39. Teva Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Teva Dermatological Remedies Product Portfolio Table 41. Teva Recent Development Table 42. Sun Pharmaceutical Company Information Table 43. Sun Pharmaceutical Business Overview Table 44. Sun Pharmaceutical Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Sun Pharmaceutical Dermatological Remedies Product Portfolio Table 46. Sun Pharmaceutical Recent Development Table 47. Johnson & Johnson Company Information Table 48. Johnson & Johnson Business Overview Table 49. Johnson & Johnson Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Johnson & Johnson Dermatological Remedies Product Portfolio Table 51. Johnson & Johnson Recent Development Table 52. Qilu Pharmaceutical Company Information Table 53. Qilu Pharmaceutical Business Overview Table 54. Qilu Pharmaceutical Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Qilu Pharmaceutical Dermatological Remedies Product Portfolio Table 56. Qilu Pharmaceutical Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis Dermatological Remedies Product Portfolio Table 61. Novartis Recent Development Table 62. Mylan Company Information Table 63. Mylan Business Overview Table 64. Mylan Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Mylan Dermatological Remedies Product Portfolio Table 66. Mylan Recent Development Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. GSK Dermatological Remedies Product Portfolio Table 71. GSK Recent Development Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Bayer Dermatological Remedies Product Portfolio Table 76. Bayer Recent Development Table 77. Lupin Company Information Table 78. Lupin Business Overview Table 79. Lupin Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Lupin Dermatological Remedies Product Portfolio Table 81. Lupin Recent Development Table 82. Lingrui Company Information Table 83. Lingrui Business Overview Table 84. Lingrui Dermatological Remedies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Lingrui Dermatological Remedies Product Portfolio Table 86. Lingrui Recent Development Table 87. Galderma Company Information Table 88. Galderma Business Overview Table 89. Galderma Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Galderma Dermatological Remedies Product Portfolio Table 91. Galderma Recent Development Table 92. Dr. Reddy's Company Information Table 93. Dr. Reddy's Business Overview Table 94. Dr. Reddy's Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Dr. Reddy's Dermatological Remedies Product Portfolio Table 96. Dr. Reddy's Recent Development Table 97. CR SANJIU Company Information Table 98. CR SANJIU Business Overview Table 99. CR SANJIU Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. CR SANJIU Dermatological Remedies Product Portfolio Table 101. CR SANJIU Recent Development Table 102. Cipla Company Information Table 103. Cipla Business Overview Table 104. Cipla Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Cipla Dermatological Remedies Product Portfolio Table 106. Cipla Recent Development Table 107. Bausch Health Company Information Table 108. Bausch Health Business Overview Table 109. Bausch Health Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bausch Health Dermatological Remedies Product Portfolio Table 111. Bausch Health Recent Development Table 112. Aurobindo Company Information Table 113. Aurobindo Business Overview Table 114. Aurobindo Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Aurobindo Dermatological Remedies Product Portfolio Table 116. Aurobindo Recent Development Table 117. Almirall Company Information Table 118. Almirall Business Overview Table 119. Almirall Dermatological Remedies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Almirall Dermatological Remedies Product Portfolio Table 121. Almirall Recent Development Table 122. North America Dermatological Remedies Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Dermatological Remedies Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Dermatological Remedies Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Dermatological Remedies Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Dermatological Remedies Revenue by Country (2021-2026) & (US$ Million) Table 128. North America Dermatological Remedies Revenue by Country (US$ Million) & (2027-2032) Table 129. Europe Dermatological Remedies Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Dermatological Remedies Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Dermatological Remedies Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Dermatological Remedies Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Dermatological Remedies Revenue by Country (2021-2026) & (US$ Million) Table 135. Europe Dermatological Remedies Revenue by Country (US$ Million) & (2027-2032) Table 136. China Dermatological Remedies Revenue by Type (2021-2026) & (US$ Million) Table 137. China Dermatological Remedies Revenue by Type (2027-2032) & (US$ Million) Table 138. China Dermatological Remedies Revenue by Application (2021-2026) & (US$ Million) Table 139. China Dermatological Remedies Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Dermatological Remedies Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Dermatological Remedies Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Dermatological Remedies Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Dermatological Remedies Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Dermatological Remedies Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Dermatological Remedies Revenue by Region (US$ Million) & (2021-2026) Table 146. Asia Dermatological Remedies Revenue by Region (US$ Million) & (2027-2032) Table 147. SAMEA Dermatological Remedies Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA Dermatological Remedies Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA Dermatological Remedies Revenue by Application (2021-2026) & (US$ Million) Table 150. SAMEA Dermatological Remedies Revenue by Application (2027-2032) & (US$ Million) Table 151. SAMEA Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. SAMEA Dermatological Remedies Revenue by Country (2021-2026) & (US$ Million) Table 153. SAMEA Dermatological Remedies Revenue by Country (US$ Million) & (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Dermatological Remedies Image Figure 2. Global Dermatological Remedies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Remedies Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anti-acne Image Figure 5. Anti-infectives Image Figure 6. Anti Psoriasis Image Figure 7. Corticosteroids Image Figure 8. Others Image Figure 9. Global Dermatological Remedies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Dermatological Remedies Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Global Dermatological Remedies Market Size (US$ Million) & (2021-2032) Figure 14. Global Dermatological Remedies Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Dermatological Remedies Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Dermatological Remedies Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Dermatological Remedies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Dermatological Remedies Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Dermatological Remedies Revenue Market Share by Type (2021-2032) Figure 21. Global Dermatological Remedies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Dermatological Remedies Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Dermatological Remedies Revenue Market Share by Application (2021-2032) Figure 24. North America Dermatological Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Dermatological Remedies Revenue Share by Type (2021-2032) Figure 26. North America Dermatological Remedies Revenue Share by Application (2021-2032) Figure 27. North America Dermatological Remedies Revenue Share by Country (2021-2032) Figure 28. United States Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Dermatological Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Dermatological Remedies Revenue Share by Type (2021-2032) Figure 33. Europe Dermatological Remedies Revenue Share by Application (2021-2032) Figure 34. Europe Dermatological Remedies Revenue Share by Country (2021-2032) Figure 35. Germany Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Dermatological Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Dermatological Remedies Revenue Share by Type (2021-2032) Figure 45. China Dermatological Remedies Revenue Share by Application (2021-2032) Figure 46. Asia Dermatological Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Dermatological Remedies Revenue Share by Type (2021-2032) Figure 48. Asia Dermatological Remedies Revenue Share by Application (2021-2032) Figure 49. Asia Dermatological Remedies Revenue Share by Region (2021-2032) Figure 50. Japan Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Dermatological Remedies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Dermatological Remedies Revenue Share by Type (2021-2032) Figure 58. SAMEA Dermatological Remedies Revenue Share by Application (2021-2032) Figure 59. SAMEA Dermatological Remedies Revenue Share by Country (2021-2032) Figure 60. Brazil Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Dermatological Remedies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-acne
  • Anti-infectives
  • Anti Psoriasis
  • Corticosteroids
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Qilu Pharmaceutical
  • Novartis
  • Mylan
  • GSK
  • Bayer
  • Lupin
  • Lingrui
  • Galderma
  • Dr. Reddy's
  • CR SANJIU
  • Cipla
  • Bausch Health
  • Aurobindo
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dermatological Remedies Market by Type
  3. 1.2.1 Global Dermatological Remedies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-acne
  5. 1.2.3 Anti-infectives
  6. 1.2.4 Anti Psoriasis
  7. 1.2.5 Corticosteroids
  8. 1.2.6 Others
  9. 1.3 Dermatological Remedies Market by Application
  10. 1.3.1 Global Dermatological Remedies Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Dermatological Remedies Market Dynamics
  1. 2.1 Dermatological Remedies Industry Trends
  2. 2.2 Dermatological Remedies Industry Drivers
  3. 2.3 Dermatological Remedies Industry Opportunities and Challenges
  4. 2.4 Dermatological Remedies Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Dermatological Remedies Market Perspective (2021-2032)
  2. 3.2 Global Dermatological Remedies Growth Trends by Region
  3. 3.2.1 Global Dermatological Remedies Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dermatological Remedies Market Size by Region (2021-2026)
  5. 3.2.3 Global Dermatological Remedies Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Dermatological Remedies Revenue by Players
  2. 4.1.1 Global Dermatological Remedies Revenue by Players (2021-2026)
  3. 4.1.2 Global Dermatological Remedies Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Dermatological Remedies Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dermatological Remedies Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Dermatological Remedies Key Players Headquarters & Area Served
  7. 4.4 Global Dermatological Remedies Players, Product Type & Application
  8. 4.5 Global Dermatological Remedies Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Dermatological Remedies Market CR5 and HHI
  11. 4.6.3 2025 Dermatological Remedies Tier 1, Tier 2, and Tier 3
5 Dermatological Remedies Market Size by Type
  1. 5.1 Global Dermatological Remedies Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Dermatological Remedies Revenue by Type (2021-2032)
  3. 5.3 Global Dermatological Remedies Revenue Market Share by Type (2021-2032)
6 Dermatological Remedies Market Size by Application
  1. 6.1 Global Dermatological Remedies Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Dermatological Remedies Revenue by Application (2021-2032)
  3. 6.3 Global Dermatological Remedies Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Dermatological Remedies Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Dermatological Remedies Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Dermatological Remedies Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Dermatological Remedies Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Dermatological Remedies Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Dermatological Remedies Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Qilu Pharmaceutical
  20. 7.4.1 Qilu Pharmaceutical Company Information
  21. 7.4.2 Qilu Pharmaceutical Business Overview
  22. 7.4.3 Qilu Pharmaceutical Dermatological Remedies Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Qilu Pharmaceutical Dermatological Remedies Product Portfolio
  24. 7.4.5 Qilu Pharmaceutical Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Dermatological Remedies Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Dermatological Remedies Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Mylan
  32. 7.6.1 Mylan Company Information
  33. 7.6.2 Mylan Business Overview
  34. 7.6.3 Mylan Dermatological Remedies Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Mylan Dermatological Remedies Product Portfolio
  36. 7.6.5 Mylan Recent Developments
  37. 7.7 GSK
  38. 7.7.1 GSK Company Information
  39. 7.7.2 GSK Business Overview
  40. 7.7.3 GSK Dermatological Remedies Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GSK Dermatological Remedies Product Portfolio
  42. 7.7.5 GSK Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Dermatological Remedies Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Dermatological Remedies Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 Lupin
  50. 7.9.1 Lupin Company Information
  51. 7.9.2 Lupin Business Overview
  52. 7.9.3 Lupin Dermatological Remedies Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lupin Dermatological Remedies Product Portfolio
  54. 7.9.5 Lupin Recent Developments
  55. 7.10 Lingrui
  56. 7.10.1 Lingrui Company Information
  57. 7.10.2 Lingrui Business Overview
  58. 7.10.3 Lingrui Dermatological Remedies Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lingrui Dermatological Remedies Product Portfolio
  60. 7.10.5 Lingrui Recent Developments
  61. 7.11 Galderma
  62. 7.11.1 Galderma Company Information
  63. 7.11.2 Galderma Business Overview
  64. 7.11.3 Galderma Dermatological Remedies Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Galderma Dermatological Remedies Product Portfolio
  66. 7.11.5 Galderma Recent Developments
  67. 7.12 Dr. Reddy's
  68. 7.12.1 Dr. Reddy's Company Information
  69. 7.12.2 Dr. Reddy's Business Overview
  70. 7.12.3 Dr. Reddy's Dermatological Remedies Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Dr. Reddy's Dermatological Remedies Product Portfolio
  72. 7.12.5 Dr. Reddy's Recent Developments
  73. 7.13 CR SANJIU
  74. 7.13.1 CR SANJIU Company Information
  75. 7.13.2 CR SANJIU Business Overview
  76. 7.13.3 CR SANJIU Dermatological Remedies Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CR SANJIU Dermatological Remedies Product Portfolio
  78. 7.13.5 CR SANJIU Recent Developments
  79. 7.14 Cipla
  80. 7.14.1 Cipla Company Information
  81. 7.14.2 Cipla Business Overview
  82. 7.14.3 Cipla Dermatological Remedies Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cipla Dermatological Remedies Product Portfolio
  84. 7.14.5 Cipla Recent Developments
  85. 7.15 Bausch Health
  86. 7.15.1 Bausch Health Company Information
  87. 7.15.2 Bausch Health Business Overview
  88. 7.15.3 Bausch Health Dermatological Remedies Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bausch Health Dermatological Remedies Product Portfolio
  90. 7.15.5 Bausch Health Recent Developments
  91. 7.16 Aurobindo
  92. 7.16.1 Aurobindo Company Information
  93. 7.16.2 Aurobindo Business Overview
  94. 7.16.3 Aurobindo Dermatological Remedies Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Aurobindo Dermatological Remedies Product Portfolio
  96. 7.16.5 Aurobindo Recent Developments
  97. 7.17 Almirall
  98. 7.17.1 Almirall Company Information
  99. 7.17.2 Almirall Business Overview
  100. 7.17.3 Almirall Dermatological Remedies Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Almirall Dermatological Remedies Product Portfolio
  102. 7.17.5 Almirall Recent Developments
8 North America
  1. 8.1 North America Dermatological Remedies Revenue (2021-2032)
  2. 8.2 North America Dermatological Remedies Revenue by Type (2021-2032)
  3. 8.2.1 North America Dermatological Remedies Revenue by Type (2021-2026)
  4. 8.2.2 North America Dermatological Remedies Revenue by Type (2027-2032)
  5. 8.3 North America Dermatological Remedies Revenue Share by Type (2021-2032)
  6. 8.4 North America Dermatological Remedies Revenue by Application (2021-2032)
  7. 8.4.1 North America Dermatological Remedies Revenue by Application (2021-2026)
  8. 8.4.2 North America Dermatological Remedies Revenue by Application (2027-2032)
  9. 8.5 North America Dermatological Remedies Revenue Share by Application (2021-2032)
  10. 8.6 North America Dermatological Remedies Revenue by Country
  11. 8.6.1 North America Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Dermatological Remedies Revenue by Country (2021-2026)
  13. 8.6.3 North America Dermatological Remedies Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Dermatological Remedies Revenue (2021-2032)
  2. 9.2 Europe Dermatological Remedies Revenue by Type (2021-2032)
  3. 9.2.1 Europe Dermatological Remedies Revenue by Type (2021-2026)
  4. 9.2.2 Europe Dermatological Remedies Revenue by Type (2027-2032)
  5. 9.3 Europe Dermatological Remedies Revenue Share by Type (2021-2032)
  6. 9.4 Europe Dermatological Remedies Revenue by Application (2021-2032)
  7. 9.4.1 Europe Dermatological Remedies Revenue by Application (2021-2026)
  8. 9.4.2 Europe Dermatological Remedies Revenue by Application (2027-2032)
  9. 9.5 Europe Dermatological Remedies Revenue Share by Application (2021-2032)
  10. 9.6 Europe Dermatological Remedies Revenue by Country
  11. 9.6.1 Europe Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Dermatological Remedies Revenue by Country (2021-2026)
  13. 9.6.3 Europe Dermatological Remedies Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Dermatological Remedies Revenue (2021-2032)
  2. 10.2 China Dermatological Remedies Revenue by Type (2021-2032)
  3. 10.2.1 China Dermatological Remedies Revenue by Type (2021-2026)
  4. 10.2.2 China Dermatological Remedies Revenue by Type (2027-2032)
  5. 10.3 China Dermatological Remedies Revenue Share by Type (2021-2032)
  6. 10.4 China Dermatological Remedies Revenue by Application (2021-2032)
  7. 10.4.1 China Dermatological Remedies Revenue by Application (2021-2026)
  8. 10.4.2 China Dermatological Remedies Revenue by Application (2027-2032)
  9. 10.5 China Dermatological Remedies Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dermatological Remedies Revenue (2021-2032)
  2. 11.2 Asia Dermatological Remedies Revenue by Type (2021-2032)
  3. 11.2.1 Asia Dermatological Remedies Revenue by Type (2021-2026)
  4. 11.2.2 Asia Dermatological Remedies Revenue by Type (2027-2032)
  5. 11.3 Asia Dermatological Remedies Revenue Share by Type (2021-2032)
  6. 11.4 Asia Dermatological Remedies Revenue by Application (2021-2032)
  7. 11.4.1 Asia Dermatological Remedies Revenue by Application (2021-2026)
  8. 11.4.2 Asia Dermatological Remedies Revenue by Application (2027-2032)
  9. 11.5 Asia Dermatological Remedies Revenue Share by Application (2021-2032)
  10. 11.6 Asia Dermatological Remedies Revenue by Country
  11. 11.6.1 Asia Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Dermatological Remedies Revenue by Country (2021-2026)
  13. 11.6.3 Asia Dermatological Remedies Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dermatological Remedies Revenue (2021-2032)
  2. 12.2 SAMEA Dermatological Remedies Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Dermatological Remedies Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Dermatological Remedies Revenue by Type (2027-2032)
  5. 12.3 SAMEA Dermatological Remedies Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Dermatological Remedies Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Dermatological Remedies Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Dermatological Remedies Revenue by Application (2027-2032)
  9. 12.5 SAMEA Dermatological Remedies Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Dermatological Remedies Revenue by Country
  11. 12.6.1 SAMEA Dermatological Remedies Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Dermatological Remedies Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Dermatological Remedies Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst